dr. monk on choosing between parp inhibitors in ovarian cancer
Published 6 years ago • 422 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
6:20
parp inhibitors in recurrent ovarian cancer
-
9:39
parp inhibitor selection in ovarian cancer
-
1:29
dr. monk on the fda approval of maintenance rucaparib in ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
11:05
parp inhibitors in recurrent ovarian cancer
-
6:50
recurrent ovarian cancer: parp inhibitors compared
-
0:53
dr. monk on combination therapies in patients with ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
6:39
difference among parp inhibitors for ovarian cancer
-
4:17
maintenance therapy in ovarian cancer: parp inhibitors
-
5:34
differences among parp inhibitors in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
3:31
ongoing parp trials in recurrent ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
7:09
ovarian cancer: comparisons between parp inhibitors
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer